malondialdehyde has been researched along with Adenocarcinoma, Follicular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djukic, SM; Jovanovic, MD; Radivojevic, SD; Simonovic, ST; Teodorovic, LC; Vrndic, OB | 1 |
| Akçay, T; Arikan, S; Demir, M; Hatemi, HH; Konukoğlu, D | 1 |
2 other study(ies) available for malondialdehyde and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Oxidative stress in patients with differentiated thyroid cancer: early effects of radioiodine therapy.
Topics: Adenocarcinoma, Follicular; Antioxidants; Carcinoma, Papillary; Case-Control Studies; Female; Humans; Iodine Radioisotopes; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Thyroid Neoplasms; Uric Acid | 2014 |
Radioiodine treatment and oxidative stress in thyroidectomised patients for differentiated thyroid cancers.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers; Carcinoma, Papillary; Erythrocyte Count; Erythrocytes; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hemoglobins; Humans; Iodine Radioisotopes; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 1998 |